Dexamethasone Doses and Glycemic Response in Diabetic Cholecystectomy
Effect of Two Different Doses of Intraoperative Dexamethasone on Glycemic Response in Diabetic Patients Undergoing Laparoscopic Cholecystectomy
This randomized double-blind controlled trial aims to compare the effects of two different doses of intraoperative intravenous dexamethasone (4 mg versus 8 mg) versus placebo on perioperative glycemic response in adult patients with diabetes mellitus undergoing laparoscopic cholecystectomy.
研究概览
地位
详细说明
Diabetes mellitus is a common comorbidity in patients undergoing surgery. Perioperative hyperglycemia is associated with increased morbidity. Dexamethasone is frequently administered intraoperatively for its antiemetic and anti-inflammatory effects, but it can cause hyperglycemia.
This randomized double-blind trial will allocate adult patients with established diabetes mellitus scheduled for elective laparoscopic cholecystectomy into three groups: Group I (4 mg dexamethasone), Group II (8 mg dexamethasone), and Group III (placebo). Blood glucose will be measured at predefined time points using a glucometer. The primary outcome is the maximum recorded perioperative blood glucose concentration within 24 hours after dexamethasone administration.
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Arwa M Mostafa, Resident
- 电话号码:01012885077
- 邮箱:Arwa.18313470@med.aun.edu.eg
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- - Adult patients aged 18 to 60 years.
- Established diabetes mellitus.
- Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
- Written informed consent.
Exclusion Criteria:
- - Patient refusal.
- Morbid obesity, cardiac diseases, hepatic diseases, or renal diseases.
- Endocrine disorders affecting glucose metabolism other than diabetes mellitus.
- Type 1 diabetes mellitus requiring continuous insulin infusion.
- Poorly controlled diabetes mellitus (HbA1c > 9.0%).
- ASA physical status III-IV.
- Recent parenteral or oral steroid therapy.
- Allergy to dexamethasone.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:4 mg Dexamethasone
Patients will receive 4 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds. |
Intravenous 4 mg dexamethasone diluted in 0.9% normal saline to 5 mL, administered over 30 seconds.
其他名称:
|
|
实验性的:8 mg Dexamethasone
Patients will receive 8 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds. |
Intravenous 8 mg dexamethasone diluted in 0.9% normal saline to 5 mL, administered over 30 seconds.
其他名称:
|
|
安慰剂比较:Placebo
Patients will receive an equivalent volume of 0.9% normal saline intravenously as placebo. |
Equivalent volume of 0.9% normal saline intravenously.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maximum Perioperative Blood Glucose Concentration
大体时间:At 24 hours
|
Maximum recorded perioperative blood glucose concentration in mg/dL within 24 hours after dexamethasone administration, measured by finger-prick capillary blood glucose using a glucometer. |
At 24 hours
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Time to Peak Blood Glucose Concentration
大体时间:At 24 hours
|
Mean time in hours from dexamethasone administration to peak blood glucose concentration. |
At 24 hours
|
|
Proportion of Patients Developing Hyperglycemia
大体时间:At 24 hours
|
Proportion of patients developing blood glucose > 180 mg/dL. |
At 24 hours
|
|
Proportion of Patients Developing Severe Hyperglycemia
大体时间:At 24 hours
|
Proportion of patients developing blood glucose > 200 mg/dL or > 250 mg/dL. |
At 24 hours
|
|
Requirement for Rescue Insulin
大体时间:At 24 hours
|
Proportion of patients requiring rescue insulin during the first 24 postoperative hours. |
At 24 hours
|
|
Incidence of Hypoglycemia
大体时间:At 24 hours
|
Proportion of patients developing blood glucose < 70 mg/dL. |
At 24 hours
|
|
Postoperative Nausea and Vomiting
大体时间:At 24 hours
|
Incidence of postoperative nausea and vomiting. |
At 24 hours
|
|
Surgical Site Infection
大体时间:At 30 days
|
Incidence of surgical site infection. |
At 30 days
|
合作者和调查者
调查人员
- 学习椅:Ola M Wahba, prof、Anaesthesia , ICU and pain management Department, Assiut University Hospitals
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.